sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> radiopharmaceuticals market

report

Radiopharmaceuticals Market, by Types (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), Applications (Diagnostic Applications, Therapeutic Applications), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC211 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the radiopharmaceuticals market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the radiopharmaceuticals market.The scope of this report covers the radiopharmaceuticals market by its major segments, which include the type, applications, procedural volume and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Deeper understanding of the behavior of the key players and innovators influencing this market
  • Granular understanding of the historical market trend and the resultant market forecast
  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive

KEY PREMIUM INSIGHTS

  • An increasing prevalence of chronic diseases such as cancer, Parkinson’s disease, Alzheimer’s disease, and cardiac failure are anticipated to increase the demand for radiopharmaceuticals market.
  • Growing awareness of radiopharmaceuticals in the emerging markets owing to the non-invasive procedure is likely to boost the market for radiopharmaceuticals.
  • Advancements in radiotracer are expected to fuel the market demand for radiopharmaceuticals during the forecast period.
  • Stringent regulatory norms coupled with the shorter half life are likely to restrain the radiopharmaceuticals market growth.
  • However, unclear reimbursement policies may hamper the radiopharmaceuticals market growth in the future.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s radiopharmaceuticals market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

KEY TARGET AUDIENCE

  • Radiopharmaceutical Manufacturing Companies
  • Suppliers and Distributors of Radiopharmaceutical
  • Research and Consulting Firm
  • Research Institute
  • Venture Capitalists
  • Contract Manufacturing Organizations
  • Contract Research Organizations

MARKET SEGMENTATION

This report analyzes the radiopharmaceuticals market by the following segments:

  • Radiopharmaceutical Market, by Types
    • Diagnostic Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • SPECT Radiopharmaceuticals
    • Therapeutic Radiopharmaceuticals
      • Alpha Emitters
      • Beta Emitters
      • Brachytherapy Isotopes
  • Radiopharmaceuticals Market, by Applications
    • Diagnostic Applications
      • PET Applications
      • SPECT Applications
    • Therapeutic Applications
      • Thyroid
      • Lymphoma
      • Bone Metastasis
      • Endocrine Tumors
      • Others Therapeutic Applications
  • Radiopharmaceutical Market, by Procedural Volume
    • Diagnostic Procedures 
      • PET Radiopharmaceuticals
      • SPECT Radiopharmaceuticals
    • Therapeutic Procedures
      • Alpha Emitters
      • Beta Emitters
      • Brachytherapy Isotopes

KEY MARKET PLAYERS

Key players in the radiopharmaceuticals market include:

  • Mallinckrodt.
  • Cardinal Health.
  • Lantheus Medical Imaging, Inc.
  • General Electric Company (GE Healthcare)
  • Bayer AG
  • Eczacibasi-Monrol Nuclear Products.
  • Advanced Accelerator Applications
  • Nordion (Canada) Inc.
  • IBA-Molecular 
  •  Bracco Imaging S.p.A. 

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • MIDDLE EAST & AFRICA
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • LATIN AMERICA
    • Brazil
    • Rest of Latin America

Radiopharmaceuticals Market

TRENDING RELATED REPORT

Active Pharmaceutical Ingredient (API) Market, by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
    3. Ecosystem Analysis
      1. Vertical Analysis
  5. RADIOPHARMACEUTICALS MARKET, BY TYPES
    1. Segment Share
    2. Types
      1. Diagnostic Radiopharmaceuticals
        1. PET Radiopharmaceuticals
        2. SPECT Radiopharmaceuticals
      2. Therapeutic Radiopharmaceuticals
        1. Alpha Emitters
        2. Beta Emitters
        3. Brachytherapy Isotopes
  6. RADIOPHARMACEUTICALS MARKET, BY APPLICATIONS
    1. Segment Share
    2. Applications
      1. Diagnostic Applications
        1. PET Applications
        2. SPECT Applications
      2. Therapeutic Applications
        1. Thyroid
        2. Lymphoma
        3. Bone Metastasis
        4. Endocrine Tumors
        5. Others Therapeutic Applications
  7. RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUME
    1. Segment Share
    2. Procedural Volume
      1. Diagnostic Procedures 
        1. PET Radiopharmaceuticals
        2. SPECT Radiopharmaceuticals
      2. Therapeutic Procedures
        1. Alpha Emitters
        2. Beta Emitters
        3. Brachytherapy Isotopes
  8. RADIOPHARMACEUTICALS MARKET, BY REGIONS
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By Applications
      4. By Procedural Volume
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Types
      3. By Applications
      4. By Procedural Volume
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Types
      3. By Applications
      4. By Procedural Volume
    4. Middle East & Africa
      1. By Country
        1. GCC
        2. North Africa
        3. South Africa
        4. Rest of Middle East & Africa
      2. By Types
      3. By Applications
      4. By Procedural Volume
    5. Latin America
      1. By Country
        1. Brazil
        2. Rest of Latin America
      2. By Types
      3. By Applications
      4. By Procedural Volume
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. Mallinckrodt.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Cardinal Health.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Lantheus Medical Imaging, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. General Electric Company (GE Healthcare)
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Bayer AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Eczacibasi-Monrol Nuclear Products.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Advanced Accelerator Applications
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Nordion (Canada) Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. IBA-Molecular
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Bracco Imaging S.p.A.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us